IP Library Assignment 025906/0416
Patent Assignment
Reel/Frame 025906/0416

Assignment of Assignor's Interest

Recorded: 2011-03-05 Pages: 7
Assignors
TAMARKIN, DOV
Executed: 2010-07-29
FRIEDMAN, DORON
Executed: 2010-08-13
BESONOV, ALEX
Executed: 2010-08-03
SHIFRIN, HELENA
Executed: 2010-07-12
Assignee
FOAMIX LTD.
2 HOLZMAN STREET, WEIZMANN SCIENCE PARK, NESS ZIONA, 74140, ISRAEL
Covered Property (1)
Carriers, Formulations, Methods for Formulating Unstable Active Agents for External Application and Uses Thereof
Patent: 8,343,945 →
Application: 12/795,164 →
Publication: US 2010/0310476
Related Assignments (10)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Jul 30, 2014
From: FOAMIX LTD.
To: FOAMIX PHARMACEUTICALS LTD.
Reel/Frame 033445/0249 →
Patent Security Agreement Jul 30, 2019
From: FOAMIX PHARMACEUTICALS LTD
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 049912/0045 →
Change of Name Nov 4, 2020
From: FOAMIX PHARMACEUTICALS LTD.
To: VYNE PHARMACEUTICALS LTD.
Reel/Frame 054306/0387 →
Assignment of Assignor's Interest Feb 4, 2021
From: VYNE PHARMACEUTICALS LTD.
To: VYNE THERAPEUTICS INC.
Reel/Frame 055215/0298 →
Patent Security Agreement Feb 17, 2021
From: VYNE THERAPEUTICS INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 055326/0009 →
Release of Security Interest Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE PHARMACEUTICALS LTD. (F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057544/0138 →
Release of Security Interest Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057544/0708 →
Assignment of Assignor's Interest Dec 22, 2021
From: VYNE THERAPEUTICS INC.
To: VYNE PHARMACEUTICALS INC.
Reel/Frame 058463/0167 →
Assignment of Assignor's Interest Feb 1, 2022
From: VYNE THERAPEUTICS INC.; VYNE PHARMACEUTICALS INC.
To: JOURNEY MEDICAL CORPORATION
Reel/Frame 058925/0568 →
Security Interest Dec 28, 2023
From: JOURNEY MEDICAL CORPORATION; JG PHARMA, INC.
To: SWK FUNDING LLC
Reel/Frame 066157/0079 →